Formation of Critical Oligomers Is a Key Event during Conformational Transition of Recombinant Syrian Hamster Prion Protein*

We have investigated the conformational transition and aggregation process of recombinant Syrian hamster prion protein (SHaPrP90–232) by Fourier transform infrared spectroscopy, circular dichroism spectroscopy, light scattering, and electron microscopy under equilibrium and kinetic conditions. SHaPrP90–232 showed an infrared absorbance spectrum typical of proteins with a predominant α-helical structure both at pH 7.0 and at pH 4.2 in the absence of guanidine hydrochloride. At pH 4.2 and destabilizing conditions (0.3–2 m guanidine hydrochloride), the secondary structure of SHaPrP90–232 was transformed to a strongly hydrogen-bonded, most probably intermolecularly arranged antiparallel β-sheet structure as indicated by dominant amide I band components at 1620 and 1691 cm-1. Kinetic analysis of the transition process showed that the decrease in α-helical structures and the increase in β-sheet structures occurred concomitantly according to a bimolecular reaction. However, the concentration dependence of the corresponding rate constant pointed to an apparent third order reaction. No β-sheet structure was formed within the dead time (190 ms) of the infrared experiments. Light scattering measurements revealed that the structural transition of SHaPrP90–232 was accompanied by formation of oligomers, whose size was linearly dependent on protein concentration. Extrapolation to zero protein concentration yielded octamers as the smallest oligomers, which are considered as “critical oligomers.” The small oligomers showed spherical and annular shapes in electron micrographs. Critical oligomers seem to play a key role during the transition and aggregation process of SHaPrP90–232. A new model for the structural transition and aggregation process of the prion protein is described.

[1]  G. J. Raymond,et al.  Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein* , 1998, The Journal of Biological Chemistry.

[2]  W. Surewicz,et al.  On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .

[3]  P. Lansbury,et al.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.

[4]  J. Bandekar,et al.  Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. , 1986, Advances in protein chemistry.

[5]  F. Cohen,et al.  Physical studies of conformational plasticity in a recombinant prion protein. , 1997, Biochemistry.

[6]  T. Wisniewski,et al.  The prionoses and other conformational disorders. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[7]  Fred E. Cohen,et al.  Folding of Prion Protein to Its Native α-Helical Conformation Is under Kinetic Control* , 2001, The Journal of Biological Chemistry.

[8]  S. Lindquist,et al.  Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.

[9]  G. Damaschun,et al.  Stopped-flow dynamic light scattering as a method to monitor compaction during protein folding , 1997, European Biophysics Journal.

[10]  F. Cohen,et al.  Self-assembly of recombinant prion protein of 106 residues. , 2000, Biochemistry.

[11]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[12]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[13]  W C Johnson,et al.  Protein secondary structure and circular dichroism: A practical guide , 1990, Proteins.

[14]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Naumann,et al.  New structural insights into the refolding of ribonuclease T1 as seen by time‐resolved Fourier‐transform infrared spectroscopy , 1999, Proteins.

[16]  A. Barth,et al.  What vibrations tell about proteins , 2002, Quarterly Reviews of Biophysics.

[17]  G. J. Raymond,et al.  Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein , 2001, Journal of neurochemistry.

[18]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[19]  W. Surewicz,et al.  pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)* , 1997, The Journal of Biological Chemistry.

[20]  R. Glockshuber.  Folding dynamics and energetics of recombinant prion proteins. , 2001, Advances in protein chemistry.

[21]  S. Provencher.  CONTIN: A general purpose constrained regularization program for inverting noisy linear algebraic and integral equations , 1984 .

[22]  T. Keiderling,et al.  Differentiation of β-Sheet-Forming Structures: Ab Initio-Based Simulations of IR Absorption and Vibrational CD for Model Peptide and Protein β-Sheets , 2001 .

[23]  D. Harris,et al.  Prion Diseases: What Is the Neurotoxic Molecule? , 2001, Neurobiology of Disease.

[24]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[25]  J. Kelly,et al.  The nucleation of monomeric parallel beta-sheet-like structures and their self-assembly in aqueous solution. , 1999, Bioorganic & medicinal chemistry.

[26]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Collinge,et al.  Multiple folding pathways for heterologously expressed human prion protein. , 1999, Biochimica et biophysica acta.

[28]  Katsuhiko Ariga,et al.  Regulation of β-Sheet Structures within Amyloid-Like β-Sheet Assemblage from Tripeptide Derivatives , 1998 .

[29]  K Wüthrich,et al.  Three-dimensional structures of prion proteins. , 2001, Advances in protein chemistry.

[30]  K Wüthrich,et al.  Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refolding , 1997, FEBS letters.

[31]  J. Torrent,et al.  Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation. , 2003, Biochimica et biophysica acta.

[32]  A. Barth,et al.  The infrared absorption of amino acid side chains. , 2000, Progress in biophysics and molecular biology.

[33]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[34]  W. Surewicz,et al.  Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. , 2000, Biochemistry.

[35]  B. Caughey,et al.  Reversibility of Scrapie-associated Prion Protein Aggregation* , 2001, The Journal of Biological Chemistry.

[36]  Ralf Masuch,et al.  Stopped Flow Apparatus for Time-Resolved Fourier Transform Infrared Difference Spectroscopy of Biological Macromolecules in 1H2O , 2003, Applied spectroscopy.

[37]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[38]  T. Pinheiro,et al.  Binding of prion protein to lipid membranes and implications for prion conversion. , 2002, Journal of molecular biology.

[39]  W. Surewicz,et al.  Disease-associated F198S Mutation Increases the Propensity of the Recombinant Prion Protein for Conformational Conversion to Scrapie-like Form* , 2002, The Journal of Biological Chemistry.

[40]  R. Riek,et al.  Recombinant full‐length murine prion protein, mPrP(23–231): purification and spectroscopic characterization , 1997, FEBS letters.

[41]  J. Chalmers,et al.  Handbook of vibrational spectroscopy , 2002 .

[42]  Isolation and characterization of a polymerized prion protein. , 2002, The Biochemical journal.

[43]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[44]  S. Hornemann,et al.  A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Mantsch,et al.  The use and misuse of FTIR spectroscopy in the determination of protein structure. , 1995, Critical reviews in biochemistry and molecular biology.

[46]  Time-resolved FTIR difference spectroscopy as tool for investigating refolding reactions of ribonuclease T1 synchronized with trans --> cis prolyl isomerization. , 2002, Biopolymers.

[47]  Dennis E. Koppel,et al.  Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .

[48]  G. Damaschun,et al.  Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation. , 2003, Journal of molecular biology.

[49]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[50]  E. Henry,et al.  [8] Singular value decomposition: Application to analysis of experimental data , 1992 .

[51]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[52]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.